Harbin Medisan Pharmaceutical Co., Ltd. approved the cash dividend of CNY 1.00 (tax included) per 10 A shares for the year 2022, at the AGM held on May 16, 2023 with an ex-date of May 31, 2023, record date on May 30, 2023 and payment date on May 31, 2023. Net cash dividend/10 shares after tax: CNY 0.90000000 (CNY 1.00000000 - CNY 0.10000000).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.87 CNY | -1.60% | -10.76% | -27.69% |
Apr. 26 | Harbin Medisan Pharmaceutical Co., Ltd. Proposes Final Dividend for 2023 | CI |
Apr. 26 | Medisan Pharma's Potassium Chloride Injection Passes Drug Regulator's Evaluation | MT |
1st Jan change | Capi. | |
---|---|---|
-27.69% | 422M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 002900 Stock
- News Harbin Medisan Pharmaceutical Co., Ltd.
- Harbin Medisan Pharmaceutical Co., Ltd. Approves the Cash Dividend for the Year 2022, Payable on May 31, 2023